Orna Acquires ReNAgade, Bringing Their Shared RNA Interests Under One Roof
Start-Ups Have Raised More Than $700m Already
Orna emerged in 2021 with its circular RNA platform and ReNAgade launched in 2023 to deliver RNA to new tissues, both backed by MPM BioImpact, but they have been partners for years.
